Federal auditors have identified that the nation’s three largest Medicare Advantage (MA) insurers denied prior authorization requests for long-term acute care and inpatient rehabilitation at significantly higher rates than other plans, according to a report released by the Office of Inspector General (OIG) for the U.S. Department of Health and Human Services. The findings, which highlight systemic disparities in how medical necessity is determined for high-acuity post-acute care, emphasize that these specific carriers disproportionately issued denials for services that were ultimately deemed medically necessary upon appeal. This oversight report, titled “Medicare Advantage Insurers’ Prior Authorization Denials for Post-Acute Care,” provides a comprehensive look at how administrative hurdles impact access to essential rehabilitation services for elderly and disabled beneficiaries.
The OIG’s investigation, which analyzed data from the 2024 plan year, indicates that the three largest insurers—which collectively cover a significant portion of the Medicare Advantage market—frequently issued initial denials that were later overturned during the internal appeal process. For patients requiring long-term acute care hospitals (LTACHs) or inpatient rehabilitation facilities (IRFs), these denials often resulted in delayed patient transfers from acute care hospitals, potentially complicating recovery timelines and increasing the length of hospital stays. According to the HHS Office of Inspector General, the agency is actively monitoring these trends to determine if current prior authorization practices are impeding access to care in violation of federal guidelines.
Understanding Prior Authorization in Post-Acute Settings
Prior authorization is a utilization management tool used by Medicare Advantage plans to determine if a requested service is medically necessary before it is performed. While intended to prevent the overutilization of healthcare resources, the OIG report suggests that for post-acute care, the process may be functioning as a barrier rather than a safeguard. In cases involving inpatient rehabilitation and long-term acute care, providers must submit clinical documentation to prove that a patient requires intensive, hospital-level therapy that cannot be safely managed in a lower-acuity setting, such as a skilled nursing facility or home health.
The discrepancy in denial rates between the largest insurers and smaller, regional Medicare Advantage plans is a point of concern for patient advocates. According to the Centers for Medicare & Medicaid Services (CMS), which oversees the regulatory framework for MA plans, insurers are obligated to ensure that their clinical criteria for coverage decisions align with original Medicare guidelines. When a large insurer denies a request at a rate higher than the industry average, it often triggers a review to see if the plan is applying more restrictive criteria than allowed under federal statute.
The Impact of Denials on Patient Outcomes
The administrative burden of fighting an initial denial can leave patients in a state of limbo. When a patient is ready for discharge from an acute care hospital but lacks an approved authorization for a rehabilitation bed, they remain in the acute setting, which is often not the optimal environment for their specific rehabilitation needs. This “boarding” effect can lead to hospital overcrowding and may increase the risk of hospital-acquired infections or functional decline for the patient.
Clinical experts note that for patients recovering from complex surgeries, strokes, or traumatic injuries, timing is critical. Delays in accessing specialized inpatient rehabilitation can diminish the window for peak recovery, as intensive therapy is most effective when initiated promptly. The Medicare Payment Advisory Commission (MedPAC) has frequently examined the role of post-acute care in the Medicare program, noting that while utilization management is necessary, it must not compromise the quality of care or the continuity of recovery services for the beneficiary.
Regulatory Scrutiny and Future Oversight
Following the release of the OIG findings, federal regulators are expected to increase scrutiny on the prior authorization workflows of the largest Medicare Advantage carriers. The OIG has recommended that CMS improve its oversight of how these plans manage post-acute care requests, specifically by requiring more transparency in the clinical algorithms used to issue denials. CMS has previously signaled an intent to standardize prior authorization processes across the Medicare Advantage program to reduce administrative burden and improve the speed of coverage determinations.
For beneficiaries and their families, the current environment necessitates a proactive approach. If a prior authorization for rehabilitation is denied, the patient or their authorized representative has the right to file an expedited appeal. According to official Medicare guidance, plans must respond to expedited appeal requests within 72 hours, a timeline designed to prevent prolonged delays in care. As the federal government continues to evaluate these findings, additional guidance regarding the use of artificial intelligence and automated systems in prior authorization is anticipated to be released by the end of the current fiscal year.
The OIG is scheduled to publish follow-up audits on insurer compliance with these authorization standards in the coming months. Readers interested in tracking these developments can monitor the OIG Audit Reports database for updates. We invite our readers to share their experiences with the prior authorization process in the comments section below to help us better understand the real-world impact of these administrative policies.
Worth a look